Drug intelligence / Profile preview

6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid is a synthetic organic compound. Specific information regarding its mechanism of action, primary indication, or developer is not readily available in public databases. While structurally related compounds, such as certain 6-oxo-4-phenyl-hexanoic acid derivatives, have been investigated as RORγt inverse agonists for immune diseases like psoriasis, there is no direct evidence linking this exact compound to such activity or any specific therapeutic development. It is likely a research chemical or an intermediate compound.

Targets

PLA2 (Phospholipase A2 group IID)

Beyond the preview

Go deeper on 6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid.

Explore the full profile